A replacement inhaler has been before the Food and Drug Administration's approval board for some time, but the FDA has taken no action to allow for another over-the-counter inhaler to be available for consumers.
Burgess criticizes the FDA for delays in approving a new asthma inhaler.
Share
More from Michael Burgess
Last week, the American people spoke forcefully against what we have seen for 4 years out of the Biden-Harris administration and their whole-of- government assault over individual freedom, economic prosperity, and limited government. For 4…
I thank the Representative from New York for yielding me the time. Mr. Speaker, I rise in support of the rule. I rise in support of the underlying bills, in particular, H.R. 9494 to provide continuing funding for the Government of the…
By direction of the Committee on Rules, I call up House Resolution 1341 and ask for its immediate consideration. The Clerk read the resolution, as follows: H. Res. 1341 Resolved, That upon adoption of this resolution it shall be in order…
Last night the House Committee on Rules met to report a rule providing for consideration of H.R. 115, the Midnight Rules Relief Act under a closed rule. The rule provides for 1 hour of general debate equally divided between the chair and…
Other voices in this conversation
